As indicated by a negative Cox score, a higher expression of SERPINA1 was found to associate with better patient survival outcome in the TCGA large patient cohort, and validated using the Curtis and Bild breast cancer patient cohorts. The gene discussed is SERPINA1; the disease is breast carcinoma.